FTC Told DOD Designation Helps Illumina-Grail Deal Appeal
By Matthew Perlman ( November 30, 2022, 7:01 PM EST) -- The Federal Trade Commission is considering whether a recent decision by the U.S. Department of Defense designating BGI Genomics as a Chinese military company bolsters attempts by agency staff to revive their challenge to the purchase of cancer-testing outfit Grail by DNA sequencing giant Illumina....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.